DE2718993A1 - Von der saeure-s abgeleitete 1-nor-2-aminocarbamate und verfahren zu ihrer herstellung - Google Patents
Von der saeure-s abgeleitete 1-nor-2-aminocarbamate und verfahren zu ihrer herstellungInfo
- Publication number
- DE2718993A1 DE2718993A1 DE19772718993 DE2718993A DE2718993A1 DE 2718993 A1 DE2718993 A1 DE 2718993A1 DE 19772718993 DE19772718993 DE 19772718993 DE 2718993 A DE2718993 A DE 2718993A DE 2718993 A1 DE2718993 A1 DE 2718993A1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- acid
- butyl
- azide
- chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002253 acid Substances 0.000 title abstract description 5
- 150000001540 azides Chemical class 0.000 title abstract description 4
- 150000004657 carbamic acid derivatives Chemical class 0.000 title abstract 2
- 238000006243 chemical reaction Methods 0.000 title description 16
- 150000001298 alcohols Chemical class 0.000 title 1
- 230000001857 anti-mycotic effect Effects 0.000 title 1
- 239000002543 antimycotic Substances 0.000 title 1
- -1 diphenylphosphoric acid azide Chemical class 0.000 claims abstract description 14
- 125000000217 alkyl group Chemical group 0.000 claims abstract 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 8
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- ULOIAOPTGWSNHU-UHFFFAOYSA-N 2-butyl radical Chemical compound C[CH]CC ULOIAOPTGWSNHU-UHFFFAOYSA-N 0.000 claims description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical compound [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 claims 1
- 238000010992 reflux Methods 0.000 abstract description 10
- 241000233866 Fungi Species 0.000 abstract description 4
- 208000031888 Mycoses Diseases 0.000 abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 3
- 241000228404 Histoplasma capsulatum Species 0.000 abstract description 2
- 241000893974 Nannizzia fulva Species 0.000 abstract description 2
- 238000000338 in vitro Methods 0.000 abstract description 2
- 230000009885 systemic effect Effects 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229930014626 natural product Natural products 0.000 abstract 1
- 238000002329 infrared spectrum Methods 0.000 description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 238000001819 mass spectrum Methods 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 150000001793 charged compounds Chemical class 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000012230 colorless oil Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 241000862997 Sorangium cellulosum Species 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000012746 preparative thin layer chromatography Methods 0.000 description 3
- 238000002798 spectrophotometry method Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69609676A | 1976-06-14 | 1976-06-14 | |
| US05/765,569 US4107429A (en) | 1976-06-14 | 1977-02-04 | 1-Nor-2-amino carbamates derived from acid S, an antibiotic produced by Polyangium cellulosum var. fulvum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2718993A1 true DE2718993A1 (de) | 1977-12-22 |
Family
ID=27105721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19772718993 Withdrawn DE2718993A1 (de) | 1976-06-14 | 1977-04-28 | Von der saeure-s abgeleitete 1-nor-2-aminocarbamate und verfahren zu ihrer herstellung |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS52153968A (enrdf_load_stackoverflow) |
| DE (1) | DE2718993A1 (enrdf_load_stackoverflow) |
| DK (1) | DK260677A (enrdf_load_stackoverflow) |
-
1977
- 1977-04-28 DE DE19772718993 patent/DE2718993A1/de not_active Withdrawn
- 1977-06-06 JP JP6659377A patent/JPS52153968A/ja active Granted
- 1977-06-13 DK DK260677A patent/DK260677A/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS52153968A (en) | 1977-12-21 |
| DK260677A (da) | 1977-12-15 |
| JPS5540587B2 (enrdf_load_stackoverflow) | 1980-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3120460C2 (enrdf_load_stackoverflow) | ||
| DE2842466A1 (de) | 2-azetidinon-derivate und verfahren zu ihrer herstellung | |
| DE3430365A1 (de) | Neue fredericamycin a-derivate | |
| DE2504045C3 (de) | 16,17 Dihydro-apovincaminsäure-2hydroxypropylester, deren Salze, Verfahren zu ihrer Herstellung und Arzneimittel | |
| US4016257A (en) | Amide derivatives of acids, an antibiotic produced by Polyangium cellulosum var. fulvum | |
| DE2954218C2 (de) | Macrolid-Antibiotika und diese Antibiotika enthaltende pharmazeutische Präparate | |
| DE2718993A1 (de) | Von der saeure-s abgeleitete 1-nor-2-aminocarbamate und verfahren zu ihrer herstellung | |
| DE2622638C2 (de) | Rifamycin-Verbindungen | |
| DE2453649C3 (de) | Verfahren zur Herstellung von Coformycin und Zwischenprodukte zu seiner Herstellung | |
| EP0022504B1 (de) | 1-N-Alkylsisomicin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE3028148A1 (de) | N-glykosylderivate der antibiotika aus der anthracylingruppe, verfahren zu deren herstellung und arzneimittel | |
| DE3133215C2 (de) | N-Methansulfonsäurederivate von Istamycin A oder B, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2517293C2 (de) | Neue Cardenolid-β-Glykoside, ihre Herstellung und Verwendung | |
| CH668598A5 (de) | Antitumor-antibiotika. | |
| DE2134085C3 (de) | Spiramycin-hydrazone | |
| EP2834240B1 (de) | Neue pyrido[3,4-c][1,9]phenanthrolin- und 11,12-dihydropyrido[3,4-c][1,9]phenanthrolin- derivate und ihre verwendung, insbesondere, zur behandlung von krebs | |
| DE69515922T2 (de) | Analogen von Acronycine, Verfahren zu ihrer Herstellung und sie enthaltende pharmaceutische Zusammensetzungen | |
| DE69610077T2 (de) | Sesquiterpenverbindungen | |
| DE2719050A1 (de) | Von der saeure-s abgeleitete diacyloxysaeuren und verfahren zu ihrer herstellung | |
| DE3041130C2 (enrdf_load_stackoverflow) | ||
| DE2659576A1 (de) | Gegen pilze wirksame substanzen und verfahren zu ihrer herstellung | |
| DE2719049A1 (de) | Von der saeure-s abgeleitete aldehyd-, oxim- und phenylhydrazonderivate | |
| DE1445821C3 (de) | S-Aminomethyl^-acylamido-ceph-Sem-4-carbonsäuren, deren Salze und Herstellung | |
| DE2659575A1 (de) | Antibiotisch wirksame substanzen und verfahren zu ihrer herstellung | |
| DE2654627C3 (de) | Oleandomycinderivate und deren nicht-toxische Säureanlagerungssalze, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende antibakterielle Arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OC | Search report available | ||
| 8139 | Disposal/non-payment of the annual fee |